

Ingredients
Per Capsule
Medicinal Ingredients
Each capsule contains Urophenol™ Cranberry, 15% proanthocyanidins (125:1 juice ectract) 240 mg (Vaccinium Macrocarpon) (fruit) equivalent to QCE 30 g.
Non-Medicinal Ingredients
Hypromellose, rice flour.
Sex-Associated or symptomatic: 2 capsules the day of and 2 capsules 24 hours later.

What are PACs and how do they work?
Proanthocyanidins (PACs) are the active molecules from cranberries that stop bacteria from adhering to the bladder wall, reducing the risk of infection. PACs have demonstrated efficacy against a variety of bacteria, including E.coli, Klebsiella pneumoniae, and Enterococcus faecalis.
What are PACs and how do they work?
Proanthocyanidins (PACs) are the active molecules from cranberries that stop bacteria from adhering to the bladder wall, reducing the risk of infection. PACs have demonstrated efficacy against a variety of bacteria, including E.coli, Klebsiella pneumoniae, and Enterococcus faecalis.

What makes Utiva UTI Control different from standard cranberry products?
What makes Utiva UTI Control different from standard cranberry products?
Utiva provides
36 mg of PACs per capsule
Standard cranberry products have a minimal amount of active molecules, PACs, (usually 0.5-1%) and therefore the amount is typically not shared. Utiva provides a 15% concentration from 240 mg of cranberry fruit extract, resulting in 36 mg of soluble PACs per capsule measured by DMAC/A2. That’s 9x more PACs than most cranberry supplements and the clinically recommended dose to provide strong anti-adhesion capabilities.

Utiva was ranked #1
in Rutgers University’s anti-adhesion activity test
All Utiva Cranberry PACs batches are sent to Rutgers University to test for Anti Adhesion Activity (AAA) which verifies the ability to stop bacteria from sticking. These tests are conducted by Amy Howell, PhD. Our anti-adhesion scores are always outstanding, with Utiva ranking high compared to other top leading brands that have soluble PAC products on the market.

Clinical Studies
01
In a case study, Utiva was shown to be effective at reducing UTI rates in long term care patients.
67%
reduction in the number of patients who experienced a UTI while receiving Utiva.1
02
In a randomized clinical trial, use of cranberry extract tablets reduced the rate of UTIs.
19%
of patients post gynecologic surgery in the cranberry group experienced UTIs compared to 38% in the placebo group.2
03
In a randomized clinical trial, it was shown that bacterial inhibition increased proportional with PAC concentration.
36 mg
of PACs was effective for achieving a bacterial anti-adhesion effect in urine with a more profound effect after consuming 72 mg.3
36 mg of PACs for UTI prevention are supported by a variety of professional associations

CUA (Canadian Urological Association)/ AUA (American Urological Association)
- This was the first time the CUA/AUA mentioned a natural product for recurrent UTI prevention (cranberry).
- “…related to Proanthocyanidins (PACs) present in cranberries and their ability to prevent the adhesion of bacteria to the urothelium.”

Family Physician Guidelines
The 2019 Anti-Infective guidelines identified 36 mg of Proanthocyanidins as the active molecule from cranberry which shows evidence for UTI prevention.

Society of Obstetricians and Gynecologists of Canada
Utiva UTI Control is recognized by the SOGC as a safe and effective product for pregnant women.
Can Utiva UTI Control and Utiva D-Mannose be taken together?
Although UTI Control and D-Mannose are individually approved by Health Canada for UTI prevention, it is recommended not to combine them in the same dose. Preliminary research shows there is decreased anti-adhesion activity of PACs from cranberries when taken at the same time as D-Mannose.
Urologist Dr. Curtis Nickel explains more during his lecture at the 2023 CUA meeting.
UTI Prevention Related Talks